Predictive Oncology Faces Competitive Landscape in Medical Supplies Industry

Analysts see Predictive Oncology's peers as having stronger growth potential despite lower valuation

Mar. 15, 2026 at 10:10am

Got story updates? Submit your updates here. ›

Predictive Oncology (NASDAQ:AGPU) is a public company in the 'Surgical, Medical, And Dental Instruments And Supplies' industry, but it faces competition from 26 other firms in the sector. A head-to-head review shows Predictive Oncology's peers have higher revenue but lower earnings per share compared to the company. While Predictive Oncology trades at a lower price-to-earnings ratio, analysts believe its competitors have more favorable growth prospects overall.

Why it matters

The medical supplies industry is highly competitive, and Predictive Oncology's performance relative to its peers is an important indicator of the company's long-term viability and growth potential. The analysis highlights Predictive Oncology's valuation advantage but also suggests its competitors may be better positioned for future success.

The details

The analysis compares Predictive Oncology to its 26 public company peers in the 'Surgical, Medical, And Dental Instruments And Supplies' industry. It looks at factors like revenue, earnings per share, valuation, volatility, institutional ownership, insider ownership, profit margins, and return on equity and assets. Overall, Predictive Oncology's peers outperform the company on 11 of the 13 metrics compared.

  • The analysis was published on March 15, 2026.

The players

Predictive Oncology Inc.

A knowledge-driven company that focuses on developing personalized cancer therapies using artificial intelligence, operating in four segments: Helomics, zPREDICTA, Soluble, and Skyline.

Got photos? Submit your photos here. ›

The takeaway

While Predictive Oncology has a valuation advantage over its peers, the analysis suggests the company faces stiff competition in the medical supplies industry. To succeed long-term, Predictive Oncology may need to differentiate itself through innovation, strategic partnerships, or other means to capitalize on its growth potential.